Embed Size (px)
Citation preview
3M Skin & Wound Care
© 3M 2010. All Rights Reserved.
Selected Cases from 3M Study 05-011258
3M™ Tegaderm™ High Performance Foam Adhesive Dressing has not been studied in a
randomized clinical trial to confirm the results of these case studies.
3M Skin & Wound Care
2
Case Study – Patient #210
Patient Demographics:
Stage 3 Pressure Ulcer on heel
19 Y/O Male
Wound duration: > 1 year
Treated for >4 weeks in Home Care
• Daily dressing changes due to lift with previous
dressing (Allevyn™ heel dressing)
Wound assessed as healed after 2 weeks with use of
Tegaderm™ High Performance Foam Adhesive Dressing,
#90619 (round)
Tegaderm™ High Performance Foam Adhesive Dressing has not been studied in a randomized clinical trial to confirm the results of these case studies.
3M Skin & Wound Care
3
Wound Progress During Treatment Period
Wound Assessments
Maceration: None assessed
Erythema: None assessed
Exudate Amount: Mild exudate assessed at baseline
and week 1
No exudate assessed at week 2
Exudate type: Serosanguinous fluid assessed at
baseline and week 1
None assessed at week 2
No adverse events reported during treatment period
Wound Size
0
1
2
3
4
5
6
7
8
9
Baseline Week 1 Week 2
Are
a cm
2
Tegaderm™ High Performance Foam Adhesive Dressing has not been studied in a randomized clinical trial to confirm the results of these case studies.
3M Skin & Wound Care
4Patient #210, Baseline, July 1, 2010 Prior to application of study dressing
3M Skin & Wound Care
5 Patient #210, Week 1, July 8, 2010
3M Skin & Wound Care
6 Patient #210, week 2, July 14, 2010 – Wound Healed
3M Skin & Wound Care
7
Case Study – Patient #303
Patient Demographics:
Venous leg ulcer – R medial malleolus
75 Y/O Female
Wound duration: 13-52 weeks
Treated for >4 weeks at Wound Clinic
• Weekly dressing changes (Allevyn™ Gentle Adhesive
Foam Dressing)
Wound assessed healed by visit week 4 with use of
Tegaderm™ High Performance Foam Adhesive Dressing,
#90612 (square)
• Note: Compression also used during treatment period
Tegaderm™ High Performance Foam Adhesive Dressing has not been studied in a randomized clinical trial to confirm the results of these case studies.
3M Skin & Wound Care
8
Wound Progress During Treatment Period
Wound Assessments
Maceration: Mild maceration assessed at baseline, but
none assessed during use of Tegaderm™ High Performance Foam Adhesive Dressing
Erythema: Mild erythema assessed at baseline and
week 2, but not assessed at any other visits
Exudate Amount: Moderate exudate assessed at baseline
Mild exudate assessed at weeks 1, 2 &3
Exudate not present at week 4 (healed)
Exudate type: Serous fluid assessed at baseline, weeks 1,
2 and 3
None assessed at week 4 (healed)
No adverse events reported during treatment period
Wound Size
0
5
10
15
20
25
30
35
Are
a cm
2
Tegaderm™ High Performance Foam Adhesive Dressing has not been studied in a randomized clinical trial to confirm the results of these case studies.
3M Skin & Wound Care
9Patient #303, Baseline Visit May 6, 2010 prior to application of study
dressing
3M Skin & Wound Care
10Patient #303, Baseline May 6, 2010 with Tegaderm™ High Performance
Foam Dressing applied
3M Skin & Wound Care
11 Patient #303, week 1 visit May 12, 2010
3M Skin & Wound Care
12Patient #303, week 2, May 20,2010 – Tegaderm™ High Performance
Foam Dressing after 1 week’s wear
3M Skin & Wound Care
13 Patient #303, week 2, May 20, 2010
3M Skin & Wound Care
14 Patient #303, week 3, May 25, 2010
3M Skin & Wound Care
15 Patient #303, week 4, June 2, 2010 Wound Healed
3M Skin & Wound Care
16
© 3M 2010. All Rights Reserved.
Learn more >>
www.3M.com/Tegaderm-FoamSS
